| 1 | Profiling of Cardiogenic Shock: Incorporating Machine Learning Into Bedside Management | 0.6 | 2 | Citations (PDF) |
| 2 | Racial Differences of Cardiac Structure and Function in Heart Failure With Preserved Ejection Fraction | 0.9 | 7 | Citations (PDF) |
| 3 | Cardiac contractility modulation in heart failure with reduced ejection fraction patients with QRS duration 120–149 ms: Reduction in heart failure hospitalizations and improvement in functional outcome | 1.9 | 6 | Citations (PDF) |
| 4 | Harvi Cardiovascular Modeling Accurately Predicts Hemodynamic Improvements Produced by a New Direct Cardiac Compression Device | 1.0 | 2 | Citations (PDF) |
| 5 | Serial Echocardiography After Greater Splanchnic Nerve Ablation In HFpEF Demonstrates Reductions In LV Filling Pressures In Clinical Responders But Not In Nonresponders: 12 Month Follow Up In The Rebalance Trial | 0.9 | 0 | Citations (PDF) |
| 6 | Systemic Circulation in Advanced Heart Failure and Cardiogenic Shock: State-of-the-Art Review | 2.7 | 4 | Citations (PDF) |
| 7 | Enhancing Sweat Rate for In-Hospital and Home-Based Decongestive Therapy | 0.9 | 3 | Citations (PDF) |
| 8 | Response by Aronson et al to Letter Regarding Article, “Enhancing Sweat Rate Using a Novel Device for the Treatment of Congestion in Heart Failure” | 2.7 | 0 | Citations (PDF) |
| 9 | Charting the Course for Careers in Interventional Heart Failure: Training, Challenges, and Future Directions | 0.6 | 0 | Citations (PDF) |
| 10 | Hierarchical physiologic pacing to enhance clinical outcomes in conduction system pacing | 1.9 | 21 | Citations (PDF) |
| 11 | Impact of Mean Blood Pressure Profiles in Percutaneous Left Ventricular Assist Device‐Supported High‐Risk Percutaneous Coronary Intervention: The PROTECT III Study | 3.1 | 3 | Citations (PDF) |
| 12 | Effects of Intracoronary SuperSaturated Oxygen Therapy on Myocardial Blood Flow, Microvascular Obstruction, and Myocardial Salvage in ST‐Segment–Elevation Myocardial Infarction in Swine Ischemia/Reperfusion Model | 3.1 | 5 | Citations (PDF) |
| 13 | Clinical outcomes of cardiogenic shock patients supported with VA-ECMO: Insights from the Cardiogenic Shock Working Group | 1.4 | 5 | Citations (PDF) |
| 14 | Acute Effects of Myeloperoxidase Inhibition on Exercise Hemodynamics in Heart Failure With Preserved Ejection Fraction: A Randomized Clinical Trial | 1.9 | 7 | Citations (PDF) |
| 15 | Outcomes with Impella CP in acute myocardial infarction vs heart failure cardiogenic shock: Insights from the Cardiogenic Shock Working Group | 1.4 | 6 | Citations (PDF) |
| 16 | Effects of Continuous Accelerated Pacing on Cardiac Structure and Function in Patients With Heart Failure With Preserved Ejection Fraction: Insights From the myPACE Randomized Clinical Trial | 3.1 | 15 | Citations (PDF) |
| 17 | The spectrum of post-myocardial infarction care: From acute ischemia to heart failure | 4.9 | 47 | Citations (PDF) |
| 18 | Streamlining Randomized Clinical Trials for Device Therapies in Heart Failure: Bayesian Borrowing of External Data | 3.1 | 2 | Citations (PDF) |
| 19 | Treatment of Acute Myocardial Infarction and Cardiogenic Shock: Outcomes of the RECOVER III Postapproval Study by Society of Cardiovascular Angiography and Interventions Shock Stage | 3.1 | 6 | Citations (PDF) |
| 20 | Case 8-2024: A 55-Year-Old Man with Cardiac Arrest, Cardiogenic Shock, and Hypoxemia | 26.4 | 2 | Citations (PDF) |
| 21 | Comprehensive RV Hemodynamic Assessment With Pressure-Volume Analysis During Impella Support | 2.3 | 3 | Citations (PDF) |
| 22 | Clinical outcomes among cardiogenic shock patients supported with high-capacity Impella axial flow pumps: A report from the Cardiogenic Shock Working Group | 1.4 | 62 | Citations (PDF) |
| 23 | Mechanical Preload Reduction: Harnessing a Cornerstone of Heart Failure Management to Improve Clinical Outcomes | 1.0 | 1 | Citations (PDF) |
| 24 | Left and Right Ventricular Hemodynamic Response After Transcatheter Mitral Valve Replacement | 1.6 | 5 | Citations (PDF) |
| 25 | Pulmonary Artery Pressures and Mortality During Venoarterial ECMO: An ELSO Registry Analysis | 2.7 | 6 | Citations (PDF) |
| 26 | Dapagliflozin Enhances Arterial and Venous Compliance During Exercise in Heart Failure With Preserved Ejection Fraction: Insights From the CAMEO-DAPA Trial | 13.1 | 38 | Citations (PDF) |
| 27 | Right Ventricular Dysfunction in Patients Undergoing High-Risk PCI with Impella | 0.9 | 5 | Citations (PDF) |
| 28 | TCT-342 Left Ventricular Performance in High-Risk Percutaneous Coronary Intervention and Impact of Prophylactic Hemodynamic Support: Insights From Pressure-Volume Analyses | 0.7 | 0 | Citations (PDF) |
| 29 | TCT-579 Comparison of Outcomes of Intra-Aortic Balloon Pump Placed Through Axillary Artery vs Femoral: A Multicenter Observational Analysis From the Cardiogenic Shock Working Group (CSWG) | 0.7 | 0 | Citations (PDF) |
| 30 | Enhancing Sweat Rate Using a Novel Device for the Treatment of Congestion in Heart Failure | 2.7 | 15 | Citations (PDF) |
| 31 | Clinical Applications of Pressure-Volume Assessment in Congenital Heart Disease | 0.6 | 9 | Citations (PDF) |
| 32 | Highlights of Innovation and Technologies and Heart Failure Therapeutics | 2.3 | 0 | Citations (PDF) |
| 33 | Multimodality Imaging of Right Heart Function | 0.7 | 131 | Citations (PDF) |
| 34 | Cardiac Tamponade With a Transaortic Percutaneous Left Ventricular Assist Device | 0.2 | 5 | Citations (PDF) |
| 35 | Patient Selection and End Point Definitions for Decongestion Studies in Acute Decompensated Heart Failure: Part 2 | 0.6 | 1 | Citations (PDF) |
| 36 | Patient Selection and End Point Definitions for Decongestion Studies in Acute Decompensated Heart Failure: Part 1 | 0.6 | 3 | Citations (PDF) |
| 37 | Device Interventions for Heart Failure | 2.9 | 18 | Citations (PDF) |
| 38 | Emerging Individualized Approaches in the Management of Acute Cardiorenal Syndrome With Renal Assist Devices | 2.9 | 13 | Citations (PDF) |
| 39 | Reverse Left Ventricular Remodeling With Transcatheter Interventions in Chronic Heart Failure Syndromes: An Updated Appraisal of the Device Landscape | 0.6 | 3 | Citations (PDF) |
| 40 | Effect of Empagliflozin on Blood Volume Redistribution in Patients With Chronic Heart Failure and Reduced Ejection Fraction: An Analysis From the Empire HF Randomized Clinical Trial | 2.7 | 36 | Citations (PDF) |
| 41 | A Glimpse Into the Future of Transcatheter Interventional Heart Failure Therapies | 2.3 | 7 | Citations (PDF) |
| 42 | Incidence and predictors of cardiogenic shock following surgical or transcatheter tricuspid valve intervention | 1.1 | 9 | Citations (PDF) |
| 43 | Intermittent Occlusion of the Superior Vena Cava to Improve Hemodynamics in Patients With Acutely Decompensated Heart Failure: The VENUS-HF Early Feasibility Study | 2.7 | 37 | Citations (PDF) |
| 44 | Remote Speech Analysis in the Evaluation of Hospitalized Patients With Acute Decompensated Heart Failure | 2.9 | 63 | Citations (PDF) |
| 45 | Machine Learning-Based Prediction of Myocardial Recovery in Patients With Left Ventricular Assist Device Support | 2.7 | 22 | Citations (PDF) |
| 46 | Invasive Right Ventricular Pressure-Volume Analysis: Basic Principles, Clinical Applications, and Practical Recommendations | 2.7 | 140 | Citations (PDF) |
| 47 | Latent Pulmonary Vascular Disease May Alter the Response to Therapeutic Atrial Shunt Device in Heart Failure | 13.1 | 127 | Citations (PDF) |
| 48 | Targeting Preload in Heart Failure: Splanchnic Nerve Blockade and Beyond | 2.7 | 21 | Citations (PDF) |
| 49 | Recovery With Temporary Mechanical Circulatory Support While Waitlisted for Heart Transplantation | 0.7 | 48 | Citations (PDF) |
| 50 | Sex related differences in exercise performance in patients with hypertrophic cardiomyopathy: Hemodynamic insights through non-invasive pressure volume analysis | 1.6 | 4 | Citations (PDF) |
| 51 | Chronic myocardial and coronary arterial effects of intracoronary supersaturated oxygen therapy in swine with normal and ischemic-reperfused myocardium | 2.7 | 4 | Citations (PDF) |
| 52 | Remote Cardiac Monitoring in Patients With Heart Failure | 8.4 | 51 | Citations (PDF) |
| 53 | Venous Tone and Stressed Blood Volume in Heart Failure | 0.7 | 108 | Citations (PDF) |
| 54 | The Challenge of Defining Best Practice Treatment for Takotsubo Syndrome With Shock | 0.4 | 1 | Citations (PDF) |
| 55 | Criteria for Defining Stages of Cardiogenic Shock Severity | 0.7 | 311 | Citations (PDF) |
| 56 | Biology of myocardial recovery in advanced heart failure with long-term mechanical support | 1.4 | 30 | Citations (PDF) |
| 57 | Right-Sided Mechanical Circulatory Support – A Hemodynamic Perspective | 2.0 | 16 | Citations (PDF) |
| 58 | Introduction to Interventional Therapies for Heart Failure: The Technology and Heart Failure Therapeutics Meeting (THT 2022) | 1.6 | 0 | Citations (PDF) |
| 59 | TCT-341 Intermittent Occlusion of the Superior Vena Cava Reduces Estimated Stressed Blood Volume in Patients With Acutely Decompensated Heart Failure | 0.7 | 0 | Citations (PDF) |
| 60 | TCT-340 Intermittent Occlusion of the Superior Vena Cava Improves Urine Sodium Excretion in Patients With Acutely Decompensated Heart Failure | 0.7 | 0 | Citations (PDF) |
| 61 | Role of Cardiac Contractility Modulation in Heart Failure With a Higher Ejection Fraction | 0.9 | 13 | Citations (PDF) |
| 62 | TCT-73 Comprehensive Right Ventricular Hemodynamic Assessment With Pressure-Volume Analysis During Impella Support: Preliminary Findings From the CHAMP-IMPELLA Study | 0.7 | 0 | Citations (PDF) |
| 63 | TCT-213 Impact of Cardiac Neuromodulation Therapy (CNT) on Systolic Blood Pressure and Pulse Pressure in Hypertensive Patients Indicated for a Pacemaker: Results of a Crossover Study | 0.7 | 0 | Citations (PDF) |
| 64 | Comparison of Risk Models in the Prediction of 30-Day Mortality in Acute Myocardial Infarction–Associated Cardiogenic Shock | 1.6 | 9 | Citations (PDF) |
| 65 | Temporary mechanical circulatory support devices: practical considerations for all stakeholders | 25.1 | 99 | Citations (PDF) |
| 66 | Pressure–Volume Profiles in Heart Failure Across Sexes and Phenotypes | 1.3 | 4 | Citations (PDF) |
| 67 | Interatrial shunt devices for the treatment of heart failure | 4.8 | 17 | Citations (PDF) |
| 68 | Dual Vasopressin Receptor Antagonism to Improve Congestion in Patients With Acute Heart Failure: Design of the AVANTI Trial | 0.9 | 24 | Citations (PDF) |
| 69 | Admission Cardiac Diagnostic Testing with Electrocardiography and Troponin Measurement Prognosticates Increased 30‐Day Mortality in COVID‐19 | 3.1 | 37 | Citations (PDF) |
| 70 | Cardiac contractility modulation for the treatment of moderate to severe HF | 1.4 | 28 | Citations (PDF) |
| 71 | Sex Differences in the Phenotype of Transthyretin Cardiac Amyloidosis Due to Val122Ile Mutation: Insights from Noninvasive Pressure–Volume Analysis | 0.9 | 35 | Citations (PDF) |
| 72 | Resist Neglecting Diastolic Dysfunction in Fontan Physiology | 0.7 | 2 | Citations (PDF) |
| 73 | Pressure-Volume Analysis Illustrating the Mechanisms of Short-Term Hemodynamic Effects Produced by Premature Ventricular Contractions | 2.7 | 5 | Citations (PDF) |
| 74 | Computational Modeling Studies of the Roles of Left Ventricular Geometry, Afterload, and Muscle Contractility on Myocardial Strains in Heart Failure with Preserved Ejection Fraction | 1.3 | 40 | Citations (PDF) |
| 75 | Estimation of Stressed Blood Volume in Patients With Cardiogenic Shock From Acute Myocardial Infarction and Decompensated Heart Failure | 0.9 | 15 | Citations (PDF) |
| 76 | Right Ventricular Pressure-Volume Analysis During a Left Ventricular Assist Device Speed Optimization Study | 2.7 | 2 | Citations (PDF) |
| 77 | Oral Milrinone for the Treatment of Chronic Severe Right Ventricular Failure in Left Ventricular Assist Device Patients | 2.7 | 8 | Citations (PDF) |
| 78 | Underutilized Fuel: Angiotensin II for Vasoplegia in the Heart Failure Patient Population | 1.0 | 2 | Citations (PDF) |
| 79 | Splanchnic Nerve Block Mediated Changes in Stressed Blood Volume in Heart Failure | 2.9 | 32 | Citations (PDF) |
| 80 | Clinical Outcomes Associated With Acute Mechanical Circulatory Support Utilization in Heart Failure Related Cardiogenic Shock | 2.7 | 95 | Citations (PDF) |
| 81 | Long‐term clinical experience with cardiac contractility modulation therapy delivered by the Optimizer Smart system | 5.0 | 68 | Citations (PDF) |
| 82 | Splanchnic nerve modulation in heart failure: mechanistic overview, initial clinical experience, and safety considerations | 5.0 | 54 | Citations (PDF) |
| 83 | Reverse Remodeling With Left Ventricular Assist Devices | 8.6 | 91 | Citations (PDF) |
| 84 | Levosimendan Improves Hemodynamics and Exercise Tolerance in PH-HFpEF | 2.9 | 81 | Citations (PDF) |
| 85 | Aortic Pulsatility Index: A Novel Hemodynamic Variable for Evaluation of Decompensated Heart Failure | 0.9 | 42 | Citations (PDF) |
| 86 | Theoretical considerations for a left atrial pump in heart failure with preserved ejection fraction | 2.8 | 8 | Citations (PDF) |
| 87 | Salutary Acute Effects of Exercise on Central Hemodynamics in Heart Failure With Preserved Ejection Fraction | 0.9 | 9 | Citations (PDF) |
| 88 | Obesity, venous capacitance, and venous compliance in heart failure with preserved ejection fraction | 5.0 | 121 | Citations (PDF) |
| 89 | Phenotyping Cardiogenic Shock | 3.1 | 223 | Citations (PDF) |
| 90 | Impact of Age on Outcomes in Patients With Cardiogenic Shock | 1.6 | 43 | Citations (PDF) |
| 91 | Pathophysiology of the Lymphatic System in Patients With Heart Failure | 0.7 | 95 | Citations (PDF) |
| 92 | Pacemaker‐Based Cardiac Neuromodulation Therapy in Patients With Hypertension: A Pilot Study | 3.1 | 29 | Citations (PDF) |
| 93 | Comprehensive Physiological Modeling Provides Novel Insights Into Heart Failure With Preserved Ejection Fraction Physiology | 3.1 | 27 | Citations (PDF) |
| 94 | Right Ventricular Pressure–Volume Analysis During Left Ventricular Assist Device Speed Optimization Studies: Insights Into Interventricular Interactions and Right Ventricular Failure | 0.9 | 21 | Citations (PDF) |
| 95 | Cardiac Contractility Modulation in Patients with Ischemic versus Non-ischemic Cardiomyopathy: Results from the MAINTAINED Observational Study | 1.6 | 19 | Citations (PDF) |
| 96 | First-in-Man 4-Chamber Pressure–Volume Analysis During Transcatheter Aortic Valve Replacement for Bicuspid Aortic Valve Disease | 0.2 | 13 | Citations (PDF) |
| 97 | Pathophysiology and Advanced Hemodynamic Assessment of Cardiogenic
Shock | 0.9 | 40 | Citations (PDF) |
| 98 | Right Ventricular Dysfunction Is Common and Identifies Patients at Risk of Dying in Cardiogenic Shock | 0.9 | 82 | Citations (PDF) |
| 99 | Right Ventricular–Pulmonary Arterial Coupling in Patients With HF Secondary MR | 1.9 | 99 | Citations (PDF) |
| 100 | Update on Cardioprotective Strategies for STEMI | 2.3 | 36 | Citations (PDF) |
| 101 | Levosimendan-Induced Venodilation is Mediated by Opening of Potassium Channels | 1.9 | 28 | Citations (PDF) |
| 102 | Rupture of Papillary Muscle and Chordae Tendinae Complicating STEMI: A Call for Action | 1.0 | 17 | Citations (PDF) |
| 103 | 158 Racial differences in val122Ile associated transthyretin cardiac amyloidosis | 0.2 | 0 | Citations (PDF) |
| 104 | Discordance Between Clinical Assessment and Invasive Hemodynamics in Patients With Advanced Heart Failure | 0.9 | 60 | Citations (PDF) |
| 105 | Invasive left ventricle pressure–volume analysis: overview and practical clinical implications | 2.6 | 227 | Citations (PDF) |
| 106 | Characterization of cardiac acoustic biomarkers in patients with heart failure | 0.4 | 17 | Citations (PDF) |
| 107 | Hemodynamic Effects of Concomitant Mitral Valve Surgery and Left Ventricular Assist Device Implantation | 1.0 | 13 | Citations (PDF) |
| 108 | Estimation of Central Venous Pressure by Pacemaker Lead Impedances in Left Ventricular Assist Device Patients | 1.0 | 2 | Citations (PDF) |
| 109 | Endovascular Ablation of the Right Greater Splanchnic Nerve for the Treatment of Heart Failure with Preserved Ejection Fraction - First-in-human Clinical Trial | 0.9 | 5 | Citations (PDF) |
| 110 | Letter by O’Neill and Burkhoff Regarding Article, “The Evolving Landscape of Impella Use in the United States Among Patients Undergoing Percutaneous Coronary Intervention With Mechanical Circulatory Support” | 13.1 | 0 | Citations (PDF) |
| 111 | Complete Hemodynamic Profiling With Pulmonary Artery Catheters in Cardiogenic Shock Is Associated With Lower In-Hospital Mortality | 2.9 | 357 | Citations (PDF) |
| 112 | Identification of Physiologic Treatment Targets with Favourable Haemodynamic Consequences in Heart Failure with Preserved Ejection Fraction | 1.9 | 13 | Citations (PDF) |
| 113 | Central Venous Pressure and Clinical Outcomes During Left-Sided Mechanical Support for Acute Myocardial Infarction and Cardiogenic Shock | 1.6 | 19 | Citations (PDF) |
| 114 | Impact of Interatrial Shunts on Invasive Hemodynamics and Exercise Tolerance in Patients With Heart Failure | 3.1 | 30 | Citations (PDF) |
| 115 | Invasive Hemodynamic Assessment and Classification of In-Hospital Mortality Risk Among Patients With Cardiogenic Shock | 2.7 | 299 | Citations (PDF) |
| 116 | Conceptual Considerations for Device-Based Therapy in Acute Decompensated Heart Failure | 2.7 | 50 | Citations (PDF) |
| 117 | Congestion in heart failure: a contemporary look at physiology, diagnosis and treatment | 25.1 | 321 | Citations (PDF) |
| 118 | Response by Brener et al to Letter Regarding Article “Effective Arterial Elastance in the Pulmonary Arterial Circulation: Derivation, Assumptions, and Clinical Applications” | 2.7 | 1 | Citations (PDF) |
| 119 | Left Ventricular Volume Reduction and Reshaping as a Treatment Option for Heart Failure | 1.6 | 21 | Citations (PDF) |
| 120 | Indications for and Findings on Transthoracic Echocardiography in COVID-19 | 2.5 | 89 | Citations (PDF) |
| 121 | Influence of Timing and Predicted Risk on Mortality in Impella-Treated Infarct-Related Cardiogenic Shock Patients | 1.6 | 36 | Citations (PDF) |
| 122 | Untangling the physiology of transthyretin cardiac amyloidosis by leveraging echocardiographically derived pressure–volume indices | 2.6 | 10 | Citations (PDF) |
| 123 | Transcatheter Aortic Valve Replacement in Left Ventricular Assist Device Patients with Aortic Regurgitation | 1.6 | 12 | Citations (PDF) |
| 124 | COVID-19 and Cardiovascular Disease | 13.1 | 1,601 | Citations (PDF) |
| 125 | The Variety of Cardiovascular Presentations of COVID-19 | 13.1 | 510 | Citations (PDF) |
| 126 | Abrupt Development of a Trans-Aortic Valve Gradient in the Setting of Acute Left-Sided Circulatory Support Identifies Right Heart Failure in Cardiogenic Shock: The Kapur-Langston Sign | 0.4 | 4 | Citations (PDF) |
| 127 | Longitudinal Trajectories of Hemodynamics Following Left Ventricular Assist Device Implantation | 0.9 | 17 | Citations (PDF) |
| 128 | Pressure-Volume Analysis Illustrating Left Ventricular Unloading by a Percutaneous Transvalvular Left Ventricular to Aortic Pump | 2.7 | 3 | Citations (PDF) |
| 129 | Safety, Performance, and Efficacy of Cardiac Contractility Modulation Delivered by the 2-Lead Optimizer Smart System | 2.7 | 73 | Citations (PDF) |
| 130 | Value of Hemodynamic Monitoring in Patients With Cardiogenic Shock Undergoing Mechanical Circulatory Support | 13.1 | 198 | Citations (PDF) |
| 131 | Hemodynamic Effects of Mechanical Circulatory Support Devices in Ventricular Septal Defect | 2.7 | 102 | Citations (PDF) |
| 132 | Assessment of Predictors of Left Atrial Volume Response to a Transcatheter InterAtrial Shunt Device (from the REDUCE LAP-HF Trial) | 1.5 | 18 | Citations (PDF) |
| 133 | Optimal Hemodynamics During Left Ventricular Assist Device Support Are Associated With Reduced Readmission Rates | 2.7 | 104 | Citations (PDF) |
| 134 | Initial experience with telemonitoring in left ventricular assist device patients | 0.9 | 29 | Citations (PDF) |
| 135 | First‐in‐human experience with occlusion of the superior vena cava to reduce cardiac filling pressures in congestive heart failure | 1.1 | 28 | Citations (PDF) |
| 136 | SCAI clinical expert consensus statement on the classification of cardiogenic shock | 1.1 | 977 | Citations (PDF) |
| 137 | Beyond Reperfusion: Acute Ventricular Unloading and Cardioprotection During Myocardial Infarction | 1.3 | 54 | Citations (PDF) |
| 138 | Trends in the Incidence of In-Hospital Mortality, Cardiogenic Shock, and Utilization of Mechanical Circulatory Support Devices in Myocarditis (Analysis of National Inpatient Sample Data, 2005–2014) | 0.9 | 65 | Citations (PDF) |
| 139 | Central and Peripheral Determinants of Exercise Capacity in Heart Failure Patients With Preserved Ejection Fraction | 2.9 | 41 | Citations (PDF) |
| 140 | The continuous heart failure spectrum: moving beyond an ejection fraction classification | 2.6 | 254 | Citations (PDF) |
| 141 | Impact of Hemodynamic Ramp Test-Guided HVAD Speed and Medication Adjustments on Clinical Outcomes | 2.7 | 89 | Citations (PDF) |
| 142 | Effects of Interatrial Shunt on Pulmonary Vascular Function in Heart Failure With Preserved Ejection Fraction | 0.7 | 89 | Citations (PDF) |
| 143 | Association of Inflow Cannula Position with Left Ventricular Unloading and Clinical Outcomes in Patients with HeartMate II Left Ventricular Assist Device | 1.0 | 37 | Citations (PDF) |
| 144 | Comparison of Percutaneous and Surgical Right Ventricular Assist Device Support After Durable Left Ventricular Assist Device Insertion | 0.9 | 42 | Citations (PDF) |
| 145 | Improvement in Biventricular Cardiac Function After Ambulatory Counterpulsation | 0.9 | 10 | Citations (PDF) |
| 146 | Cardiac Contractility Modulation Improves Long-Term Survival and Hospitalizations in Heart Failure with Reduced Ejection Fraction | 5.0 | 97 | Citations (PDF) |
| 147 | Cardiac Contractility Modulation: Mechanisms of Action in Heart Failure with Reduced Ejection Fraction and Beyond | 5.0 | 105 | Citations (PDF) |
| 148 | Intermittent Occlusion of the Superior Vena Cava Reduces Cardiac Filling Pressures in Preclinical Models of Heart Failure | 1.3 | 21 | Citations (PDF) |
| 149 | Acute Cardiac Unloading and Recovery - Proceedings | 1.4 | 0 | Citations (PDF) |
| 150 | Long-Acting Octreotide Reduces the Recurrence of Gastrointestinal Bleeding in Patients With a Continuous-Flow Left Ventricular Assist Device | 0.9 | 36 | Citations (PDF) |
| 151 | Distinct Hemodynamic Changes After Interventional Mitral Valve Edge‐to‐Edge Repair in Different Phenotypes of Heart Failure: An Integrated Hemodynamic Analysis | 3.1 | 14 | Citations (PDF) |
| 152 | 3D Morphological Changes in LV and RV During LVAD Ramp Studies | 3.9 | 73 | Citations (PDF) |
| 153 | Low-flow support of the chronic pressure–overloaded right ventricle induces reversed remodeling | 1.4 | 18 | Citations (PDF) |
| 154 | Right Ventricular Dysfunction in Acute Myocardial Infarction Complicated by Cardiogenic Shock: A Hemodynamic Analysis of the Should We Emergently Revascularize Occluded Coronaries for Cardiogenic Shock (SHOCK) Trial and Registry | 0.9 | 98 | Citations (PDF) |
| 155 | Cannula and Pump Positions Are Associated With Left Ventricular Unloading and Clinical Outcome in Patients With HeartWare Left Ventricular Assist Device | 0.9 | 25 | Citations (PDF) |
| 156 | Extracorporeal Membrane Oxygenation for End-Stage Interstitial Lung Disease With Secondary Pulmonary Hypertension at Rest and Exercise: Insights From Simulation Modeling | 1.0 | 7 | Citations (PDF) |
| 157 | Repeated Ramp Tests on Stable LVAD Patients Reveal Patient-Specific Hemodynamic Fingerprint | 1.0 | 12 | Citations (PDF) |
| 158 | Transcatheter Interatrial Shunt Device for the Treatment of Heart Failure With Preserved Ejection Fraction (REDUCE LAP-HF I [Reduce Elevated Left Atrial Pressure in Patients With Heart Failure]) | 13.1 | 265 | Citations (PDF) |
| 159 | Increasing Opportunity for Lung Transplant in Interstitial Lung Disease With Pulmonary Hypertension | 2.6 | 38 | Citations (PDF) |
| 160 | Impact of Baseline Hemodynamics on the Effects of a Transcatheter Interatrial Shunt Device in Heart Failure With Preserved Ejection Fraction | 2.7 | 30 | Citations (PDF) |
| 161 | Omega-3 Therapy Is Associated With Reduced Gastrointestinal Bleeding in Patients With Continuous-Flow Left Ventricular Assist Device | 2.7 | 57 | Citations (PDF) |
| 162 | Meta‐Analysis Global Group in Chronic (MAGGIC) Heart Failure Risk Score: Validation of a Simple Tool for the Prediction of Morbidity and Mortality in Heart Failure With Preserved Ejection Fraction | 3.1 | 169 | Citations (PDF) |
| 163 | Venoarterial Extracorporeal Membrane Oxygenation for Cardiogenic Shock and Cardiac Arrest | 2.7 | 535 | Citations (PDF) |
| 164 | One-Year Safety and Clinical Outcomes of a Transcatheter Interatrial Shunt Device for the Treatment of Heart Failure With Preserved Ejection Fraction in the Reduce Elevated Left Atrial Pressure in Patients With Heart Failure (REDUCE LAP-HF I) Trial | 8.4 | 153 | Citations (PDF) |
| 165 | Rationale and evidence for the development of a durable device-based cardiac neuromodulation therapy for hypertension | 2.3 | 7 | Citations (PDF) |
| 166 | Mechanical Unloading in Heart Failure | 0.7 | 176 | Citations (PDF) |
| 167 | Investigating the Role of Interventricular Interdependence in Development of Right Heart Dysfunction During LVAD Support: A Patient-Specific Methods-Based Approach | 2.2 | 57 | Citations (PDF) |
| 168 | Echocardiographic Predictors of Hemodynamics in Patients Supported With Left Ventricular Assist Devices | 0.9 | 13 | Citations (PDF) |
| 169 | A Randomized Controlled Trial to Evaluate the Safety and Efficacy of Cardiac Contractility Modulation | 2.9 | 248 | Citations (PDF) |
| 170 | Mechanical Unloading by Fulminant Myocarditis: LV-IMPELLA, ECMELLA, BI-PELLA, and PROPELLA Concepts | 1.3 | 159 | Citations (PDF) |
| 171 | Evaluation of remote dielectric sensing (ReDS) technology-guided therapy for decreasing heart failure re-hospitalizations | 1.6 | 132 | Citations (PDF) |
| 172 | Stress Testing in Asymptomatic Aortic Stenosis | 13.1 | 63 | Citations (PDF) |
| 173 | Methodological Issues and Their Impact on Conclusions | 1.9 | 1 | Citations (PDF) |
| 174 | Hemodynamics of Cardiogenic Shock | 0.2 | 29 | Citations (PDF) |
| 175 | Device-based Therapy for Mitral Regurgitation and Ventricular Reshaping | 1.6 | 3 | Citations (PDF) |
| 176 | Decoupling Between Diastolic Pulmonary Artery Pressure and Pulmonary Capillary Wedge Pressure as a Prognostic Factor After Continuous Flow Ventricular Assist Device Implantation | 2.7 | 62 | Citations (PDF) |
| 177 | Mechanical Circulatory Support Devices for Acute Right Ventricular Failure | 13.1 | 339 | Citations (PDF) |
| 178 | Organ‐level validation of a cross‐bridge cycling descriptor in a left ventricular finite element model: effects of ventricular loading on myocardial strains | 1.1 | 34 | Citations (PDF) |
| 179 | Use of an iPad App to simulate pressure-volume loops and cardiovascular physiology | 0.8 | 13 | Citations (PDF) |
| 180 | Avoiding hemodynamic collapse during high‐risk percutaneous coronary intervention: Advanced hemodynamics of impella support | 1.1 | 15 | Citations (PDF) |
| 181 | Systolic and diastolic unloading by mechanical support of the acute vs the chronic pressure overloaded right ventricle | 1.4 | 13 | Citations (PDF) |
| 182 | Left ventricular assist device-induced reverse remodeling: it’s not just about myocardial recovery | 1.4 | 44 | Citations (PDF) |
| 183 | Pacemaker‐Mediated Programmable Hypertension Control Therapy | 3.1 | 29 | Citations (PDF) |
| 184 | Reverse remodelling and myocardial recovery in heart failure | 25.1 | 211 | Citations (PDF) |
| 185 | Partial LVAD Restores Ventricular Outputs and Normalizes LV but not RV Stress Distributions in the Acutely Failing Heart in Silico | 0.9 | 39 | Citations (PDF) |
| 186 | Accuracy of the HVAD Pump Flow Estimation Algorithm | 1.0 | 30 | Citations (PDF) |
| 187 | Validation of remote dielectric sensing (ReDS™) technology for quantification of lung fluid status: Comparison to high resolution chest computed tomography in patients with and without acute heart failure | 1.6 | 120 | Citations (PDF) |
| 188 | Transcatheter Interatrial Shunt Device for the Treatment of Heart Failure | 2.7 | 58 | Citations (PDF) |
| 189 | Hemodynamic Ramp Tests in Patients With Left Ventricular Assist Devices | 2.9 | 202 | Citations (PDF) |
| 190 | Cardiovascular Simulation of Heart Failure Pathophysiology and Therapeutics | 0.9 | 66 | Citations (PDF) |
| 191 | Long-term survival after MitraClip® therapy in patients with severe mitral regurgitation and severe congestive heart failure: A comparison among survivals predicted by heart failure models | 2.0 | 23 | Citations (PDF) |
| 192 | Physiological Characterization of the SynCardia Total Artificial Heart in a Mock Circulation System | 1.0 | 25 | Citations (PDF) |
| 193 | Innovative devices for advanced heart failure | 1.0 | 3 | Citations (PDF) |
| 194 | Hemodynamics of Mechanical Circulatory Support | 0.7 | 551 | Citations (PDF) |
| 195 | Mechanical support of the pressure overloaded right ventricle: an acute feasibility study comparing low and high flow support | 2.3 | 26 | Citations (PDF) |
| 196 | Efficacy and survival in patients with cardiac contractility modulation: Long-term single center experience in 81 patients | 1.6 | 86 | Citations (PDF) |
| 197 | Left Ventricular Decompression During Speed Optimization Ramps in Patients Supported by Continuous-Flow Left Ventricular Assist Devices: Device-Specific Performance Characteristics and Impact on Diagnostic Algorithms | 0.9 | 74 | Citations (PDF) |
| 198 | Left Atrial Decompression Pump for Severe Heart Failure With Preserved Ejection Fraction | 2.9 | 76 | Citations (PDF) |
| 199 | Diastolic pressure–volume quotient (DPVQ) as a novel echocardiographic index for estimation of LV stiffness in HFpEF | 1.5 | 42 | Citations (PDF) |
| 200 | A Randomized Controlled Trial to Evaluate the Safety and Efficacy of Cardiac Contractility Modulation in Patients With Moderately Reduced Left Ventricular Ejection Fraction and a Narrow QRS Duration: Study Rationale and Design | 0.9 | 46 | Citations (PDF) |
| 201 | Effects of an Interatrial Shunt on Rest and Exercise Hemodynamics: Results of a Computer Simulation in Heart Failure | 0.9 | 137 | Citations (PDF) |
| 202 | Systolic heart failure and cardiac resynchronization therapy: a focus on diastole | 0.9 | 10 | Citations (PDF) |
| 203 | Functional Mitral Regurgitation: Therapeutic Strategies for a Ventricular Disease | 0.9 | 21 | Citations (PDF) |
| 204 | Evolution of Renal Function after Partial and Full Mechanical Support for Chronic Heart Failure | 0.9 | 14 | Citations (PDF) |
| 205 | Hemodynamic Support | 0.2 | 6 | Citations (PDF) |
| 206 | Partial mechanical circulatory support in an ovine model of post-infarction remodeling | 1.4 | 14 | Citations (PDF) |
| 207 | Modeling left atrial volume, shape, and contraction patterns in normal subjects by cardiac magnetic resonance imaging | 1.6 | 7 | Citations (PDF) |
| 208 | Cardiac contractility modulation in patients with advanced heart failure | 1.2 | 13 | Citations (PDF) |
| 209 | Transmyocardial Laser Revascularization | 1.9 | 7 | Citations (PDF) |
| 210 | Mortality in heart failure with preserved ejection fraction: an unacceptably high rate | 2.6 | 38 | Citations (PDF) |
| 211 | The use of a CircuLite micro-pump for congenitally corrected transposition of the great arteries | 1.2 | 11 | Citations (PDF) |
| 212 | Myocardial Recovery and the Failing Heart | 0.7 | 274 | Citations (PDF) |
| 213 | Right ventricular assist device in end-stage pulmonary arterial hypertension: insights from a computational model of the cardiovascular system | 4.9 | 68 | Citations (PDF) |
| 214 | Current Clinical Experience with the Synergy® Micro-Pump System in Chronic Ambulatory Heart Failure | 0.9 | 0 | Citations (PDF) |
| 215 | Two axial-flow Synergy Micro-Pumps as a biventricular assist device in an ovine animal model | 1.4 | 19 | Citations (PDF) |
| 216 | The science behind percutaneous hemodynamic support: A review and comparison of support strategies | 1.1 | 95 | Citations (PDF) |
| 217 | Is Myocardial Recovery Possible and How Do You Measure It? | 2.3 | 28 | Citations (PDF) |
| 218 | The Impact of Extra Cardiac Comorbidities on Pressure Volume Relations in Heart Failure and Preserved Ejection Fraction | 0.9 | 42 | Citations (PDF) |
| 219 | Subgroup Analysis of a Randomized Controlled Trial Evaluating the Safety and Efficacy of Cardiac Contractility Modulation in Advanced Heart Failure | 0.9 | 103 | Citations (PDF) |
| 220 | Reply to the Editor | 2.2 | 0 | Citations (PDF) |
| 221 | Baseline Left Ventricular Volume and Shape as Determinants of Reverse Remodeling Induced by Surgical Ventricular Reconstruction | 2.6 | 11 | Citations (PDF) |
| 222 | Does Contractility Modulation Have a Role in the Treatment of Heart Failure? | 2.0 | 7 | Citations (PDF) |
| 223 | Clinical benefits of partial circulatory support in New York Heart Association Class IIIB and Early Class IV patients | 1.2 | 79 | Citations (PDF) |
| 224 | Impact of surgical ventricular reconstruction on stroke volume in patients with ischemic cardiomyopathy | 2.2 | 26 | Citations (PDF) |
| 225 | Single-beat estimation of the left ventricular end-diastolic pressure–volume relationship in patients with heart failure | 2.6 | 42 | Citations (PDF) |
| 226 | The Ventilatory Anaerobic Threshold in Heart Failure: A Multicenter Evaluation of Reliability | 0.9 | 59 | Citations (PDF) |
| 227 | Reply | 0.9 | 0 | Citations (PDF) |
| 228 | Mechanisms Underlying Improvements in Ejection Fraction With Carvedilol in Heart Failure | 2.7 | 69 | Citations (PDF) |
| 229 | Partial left ventricular support implanted through minimal access surgery as a bridge to cardiac transplant | 2.2 | 16 | Citations (PDF) |
| 230 | Comparison of Ventricular Structure and Function in Chinese Patients With Heart Failure and Ejection Fractions >55% Versus 40% to 55% Versus <40% | 1.5 | 72 | Citations (PDF) |
| 231 | Heart failure with normal ejection fraction: Consideration of mechanisms other than diastolic dysfunction | 2.0 | 38 | Citations (PDF) |
| 232 | A Multicenter Study of Noninvasive Cardiac Output by Bioreactance During Symptom-limited Exercise | 0.9 | 51 | Citations (PDF) |
| 233 | Skeletal Muscle Function Predicts Both Peak Oxygen Consumption and Peak Cardiac Output in Patients with Stable Congestive Heart Failure | 0.9 | 0 | Citations (PDF) |
| 234 | Proof of Concept | 0.7 | 121 | Citations (PDF) |
| 235 | Impact of Cardiac Contractility Modulation on Left Ventricular Global and Regional Function and Remodeling | 3.9 | 97 | Citations (PDF) |
| 236 | Impact of left ventricular assist device (LVAD) support on the cardiac reverse remodeling process | 2.9 | 108 | Citations (PDF) |
| 237 | Cardiac Contractility Modulation Electrical Signals Improve Myocardial Gene Expression in Patients With Heart Failure | 0.7 | 162 | Citations (PDF) |
| 238 | A randomized controlled trial to evaluate the safety and efficacy of cardiac contractility modulation in patients with systolic heart failure: Rationale, design, and baseline patient characteristics | 1.8 | 40 | Citations (PDF) |
| 239 | First human use of partial left ventricular heart support with the Circulite™ synergy™ micro-pump as a bridge to cardiac transplantation | 2.6 | 34 | Citations (PDF) |
| 240 | The impact of left ventricular assist device-induced left ventricular unloading on the myocardial renin-angiotensin-aldosterone system: therapeutic consequences? | 2.6 | 104 | Citations (PDF) |
| 241 | Markers of Ventilatory Inefficiency in Heart Failure Are Related to Peak Exercise Cardiac Output Measured with Novel Bioreactance Technology | 0.9 | 1 | Citations (PDF) |
| 242 | Ventricular Structure and Function in Hypertensive Participants With Heart Failure and a Normal Ejection Fraction | 0.7 | 178 | Citations (PDF) |
| 243 | The Impact of Angiotensin-Converting Enzyme Inhibitor Therapy on the Extracellular Collagen Matrix During Left Ventricular Assist Device Support in Patients With End-Stage Heart Failure | 0.7 | 97 | Citations (PDF) |
| 244 | Hemodynamic effects of partial ventricular support in chronic heart failure: Results of simulation validated with in vivo data | 2.2 | 108 | Citations (PDF) |
| 245 | To the Editor | 1.9 | 0 | Citations (PDF) |
| 246 | LVAD-Induced Reverse Remodeling: Basic and Clinical Implications for Myocardial Recovery | 0.9 | 174 | Citations (PDF) |
| 247 | A randomized multicenter clinical study to evaluate the safety and efficacy of the TandemHeart percutaneous ventricular assist device versus conventional therapy with intraaortic balloon pumping for treatment of cardiogenic shock | 1.8 | 519 | Citations (PDF) |
| 248 | Cardiomyopathic Etiology and SERCA2a Reverse Remodeling During Mechanical Support of the Failing Human Heart | 1.5 | 17 | Citations (PDF) |
| 249 | Treating heart failure with cardiac contractility modulation electrical signals | 2.0 | 13 | Citations (PDF) |
| 250 | Ventricular Pump Function in Heart Failure with Normal Ejection Fraction: Insights from Pressure-Volume Measurements | 4.9 | 33 | Citations (PDF) |
| 251 | Feasibility study of the use of the TandemHeart® percutaneous ventricular assist device for treatment of cardiogenic shock | 1.1 | 53 | Citations (PDF) |
| 252 | Single-beat estimation of end-diastolic pressure-volume relationship: a novel method with potential for noninvasive application | 2.3 | 275 | Citations (PDF) |
| 253 | A polymerized bovine hemoglobin oxygen carrier preserves regional myocardial function and reduces infarct size after acute myocardial ischemia | 2.3 | 45 | Citations (PDF) |
| 254 | Development of Heart Failure in Chronic Hypertensive Dahl Rats | 4.7 | 141 | Citations (PDF) |
| 255 | Assessment of systolic and diastolic ventricular properties via pressure-volume analysis: a guide for clinical, translational, and basic researchers | 2.3 | 732 | Citations (PDF) |
| 256 | Role of impaired myocardial relaxation in the production of elevated left ventricular filling pressure | 2.3 | 102 | Citations (PDF) |
| 257 | Mechanical Unloading During Left Ventricular Assist Device Support Increases Left Ventricular Collagen Cross-Linking and Myocardial Stiffness | 13.1 | 196 | Citations (PDF) |
| 258 | Mechanical Device–Based Methods of Managing and Treating Heart Failure | 13.1 | 87 | Citations (PDF) |
| 259 | Sarcomeric genes involved in reverse remodeling of the heart during left ventricular assist device support | 1.4 | 78 | Citations (PDF) |
| 260 | Biventricular Assist Device-Induced Right Ventricular Reverse Structural and Functional Remodeling | 1.4 | 52 | Citations (PDF) |
| 261 | Intramyocardial Left Ventricle-to-Coronary Artery Stent: A Novel Approach for the Treatment of Coronary Artery Disease | 2.6 | 3 | Citations (PDF) |
| 262 | Cardioprotection before revascularization in ischemic myocardial injury and the potential role of hemoglobin-based oxygen carriers | 1.8 | 13 | Citations (PDF) |
| 263 | Left Heart Failure With a Normal Ejection Fraction: Identification of Different Pathophysiologic Mechanisms | 0.9 | 202 | Citations (PDF) |
| 264 | Left ventricular assist device support normalizes left and right ventricular beta-adrenergic pathway properties | 0.7 | 95 | Citations (PDF) |
| 265 | Electrical Signals Applied During the Absolute Refractory Period | 0.7 | 76 | Citations (PDF) |
| 266 | Diastolic Heart Failure | 26.4 | 9 | Citations (PDF) |
| 267 | Mechanisms of heart failure with well preserved ejection fraction in dogs following limited coronary microembolization | 5.7 | 52 | Citations (PDF) |
| 268 | Outcomes Following Percutaneous Coronary Intervention in Patients Previously Considered "Without Option":. A Subgroup Analysis of the PACIFIC Trial | 0.3 | 7 | Citations (PDF) |
| 269 | Diastolic dysfunction | 0.7 | 194 | Citations (PDF) |
| 270 | Development and validation of a patient questionnaire to determine New York heart association classification | 0.9 | 96 | Citations (PDF) |
| 271 | Use of Rapamycin Slows Progression of Cardiac Transplantation Vasculopathy | 13.1 | 503 | Citations (PDF) |
| 272 | β-Blockers Restore Calcium Release Channel Function and Improve Cardiac Muscle Performance in Human Heart Failure | 13.1 | 299 | Citations (PDF) |
| 273 | Protein Kinase A Phosphorylation of the Cardiac Calcium Release Channel (Ryanodine Receptor) in Normal and Failing Hearts | 1.3 | 194 | Citations (PDF) |
| 274 | Electric currents applied during refractory period enhance contractility and systolic calcium in the ferret heart | 2.3 | 58 | Citations (PDF) |
| 275 | Alternatives to traditional coronary bypass surgery | 1.3 | 5 | Citations (PDF) |
| 276 | Load dependence of ventricular performance explained by model of calcium-myofilament interactions | 2.3 | 34 | Citations (PDF) |
| 277 | Disease-specific remodeling of cardiac mitochondria after a left ventricular assist device | 2.6 | 64 | Citations (PDF) |
| 278 | Invited commentary | 2.6 | 1 | Citations (PDF) |
| 279 | Do transmyocardial and percutaneous laser revascularization induce silent ischemia? An assessment by exercise testing | 1.8 | 29 | Citations (PDF) |
| 280 | Direct cardiac compression devices | 1.4 | 38 | Citations (PDF) |
| 281 | Cardiac contractility modulation by electric currents applied during the refractory period | 2.3 | 74 | Citations (PDF) |
| 282 | Time course of reverse remodeling of the left ventricle during support with a left ventricular assist device | 2.2 | 150 | Citations (PDF) |
| 283 | Variability of myocardial perfusion defects assessed by thallium-201 scintigraphy in patients with coronary artery disease not amenable to angioplasty or bypass surgery | 0.7 | 29 | Citations (PDF) |
| 284 | Assessment of segmental wall motion abnormalities using contrast two-dimensional echocardiography in awake mice | 2.3 | 21 | Citations (PDF) |
| 285 | Anesthetic inhibition in ischemic and nonischemic murine heart: comparison with conscious echocardiographic approach | 2.3 | 56 | Citations (PDF) |
| 286 | Title is missing! | 1.4 | 3 | Citations (PDF) |
| 287 | Title is missing! | 2.8 | 73 | Citations (PDF) |
| 288 | Direct coronary artery perfusion from the left ventricle | 2.2 | 18 | Citations (PDF) |
| 289 | New heart failure therapy: The shape of things to come? | 2.2 | 17 | Citations (PDF) |
| 290 | Left ventricular volume reduction surgery for heart failure: A physiologic perspective | 2.2 | 62 | Citations (PDF) |
| 291 | Selective Renal Vasodilation and Active Renal Artery Perfusion Improve Renal Function in Dogs with Acute Heart Failure | 2.3 | 2 | Citations (PDF) |
| 292 | Radio frequency transmyocardial revascularization enhances angiogenesis and causes myocardial denervation in canine model | 1.0 | 34 | Citations (PDF) |
| 293 | Left ventricular assist device-induced reverse ventricular remodeling | 4.9 | 59 | Citations (PDF) |
| 294 | Maximizing hemodynamic effectiveness of biventricular assistance by direct cardiac compression studied in ex vivo and in vivo canine models of acute heart failure | 2.2 | 16 | Citations (PDF) |
| 295 | Histologic evidence that basic fibroblast growth factor enhances the angiogenic effects of transmyocardial laser revascularization | 5.4 | 33 | Citations (PDF) |
| 296 | PKA Phosphorylation Dissociates FKBP12.6 from the Calcium Release Channel (Ryanodine Receptor) | 23.4 | 1,947 | Citations (PDF) |
| 297 | Factors contributing to pressure overload-induced immediate early gene expression in adult rat hearts in vivo | 2.3 | 4 | Citations (PDF) |
| 298 | An Examination of Potential Mechanisms Underlying Transmyocardial Laser Revascularization Induced Increases in Myocardial Blood Flow | 1.3 | 21 | Citations (PDF) |
| 299 | Transmyocardial laser revascularisation compared with continued medical therapy for treatment of refractory angina pectoris: a prospective randomised trial | 46.9 | 303 | Citations (PDF) |
| 300 | Holmium: YAG laser transmyocardial revascularization relieves angina and improves functional status | 2.6 | 76 | Citations (PDF) |
| 301 | Factors correlating with risk of mortality after transmyocardial revascularization | 0.7 | 33 | Citations (PDF) |
| 302 | The Role of Angiotensin II AT1 Receptor in the Maintenance of Hemodynamics in a Canine Model of Coronary Microembolization-Induced Heart Failure | 1.4 | 6 | Citations (PDF) |
| 303 | Inhaled Nitric Oxide Is Not A Myocardial Depressant In A Porcine Model Of Heart Failure | 2.2 | 20 | Citations (PDF) |
| 304 | Early Activation of Metalloproteinases after Experimental Myocardial Infarction Occurs in Infarct and Non-infarct Zones | 1.2 | 46 | Citations (PDF) |
| 305 | Inflow Valve Regurgitation During Left Ventricular Assist Device Support May Interfere With Reverse Ventricular Remodeling | 2.6 | 19 | Citations (PDF) |
| 306 | Evidence of Vascular Growth Associated With Laser Treatment of Normal Canine Myocardium | 2.6 | 99 | Citations (PDF) |
| 307 | Angiogenesis Is Enhanced in Ischemic Canine Myocardium by Transmyocardial Laser Revascularization 11This study was supported in part by a research grant from CardioGenesis Corporation, Sunnyvale, California. | 0.7 | 150 | Citations (PDF) |
| 308 | Metabolic inhibition in the perfused rat heart: evidence for glycolytic requirement for normal sodium homeostasis | 2.3 | 25 | Citations (PDF) |
| 309 | Effect of BAY y 5959 on myocardial function and metabolism in normal and failing hearts | 2.3 | 2 | Citations (PDF) |
| 310 | Effect of ventricular stretch on contractile strength, calcium transient, and cAMP in intact canine hearts | 2.3 | 29 | Citations (PDF) |
| 311 | Hemodynamic Effects of a Calcium Channel Promoter, BAY y 5959, are Preserved after Chronic Administration in Ischemic Heart Failure in Conscious Dogs | 2.3 | 2 | Citations (PDF) |
| 312 | Coronary Endothelial Dysfunction Precedes Heart Failure and Reduction of Coronary Reserve in Awake Dogs | 2.7 | 46 | Citations (PDF) |
| 313 | Physiology, histology, and 2-week morphology of acute transmyocardial channels made with a CO2 laser | 2.6 | 115 | Citations (PDF) |
| 314 | Histologic analysis of transmyocardial channels: comparison of CO2 and holmium: YAG lasers | 2.6 | 125 | Citations (PDF) |
| 315 | Characterizing ventricular mechanics and energetics following repeated coronary microembolization | 2.3 | 7 | Citations (PDF) |
| 316 | Role for Holmium: YAG Lasers in Transmyocardial Laser Revascularization | 2.2 | 5 | Citations (PDF) |
| 317 | Angiogenesis: A Possible Mechanism Underlying the Clinical Benefits of Transmyocardial Laser Revascularization | 2.2 | 40 | Citations (PDF) |
| 318 | Inhaled nitric oxide is not a negative inotropic agent in a porcine model of pulmonary hypertension | 2.2 | 14 | Citations (PDF) |
| 319 | Myocardial perfusion through naturally occurring subendocardial channels | 2.2 | 12 | Citations (PDF) |
| 320 | Heart reduction surgery: An analysis of the impact on cardiac function | 2.2 | 120 | Citations (PDF) |
| 321 | Systolic ventricular interaction in normal and diseased explanted human hearts | 2.2 | 14 | Citations (PDF) |
| 322 | Assessment of Transmyocardial Perfusion in Alligator Hearts | 13.1 | 66 | Citations (PDF) |
| 323 | Physical Training Alters the Pathogenesis of Pacing-Induced Heart Failure Through Endothelium-Mediated Mechanisms in Awake Dogs | 13.1 | 46 | Citations (PDF) |
| 324 | Glycolysis is required for normal sodium homeostasis in perfused rat hearts | 0.7 | 0 | Citations (PDF) |
| 325 | Does blood flow through holmium: YAG transmyocardial laser channels? | 2.6 | 137 | Citations (PDF) |
| 326 | Histologic appearance of transmyocardial laser Channels after 41/2 Weeks | 2.6 | 160 | Citations (PDF) |
| 327 | Validation of right and left ventricular conductance and echocardiography for cardiac function studies | 2.6 | 23 | Citations (PDF) |
| 328 | Does blood flow through transmyocardial CO2laser channels? | 0.7 | 6 | Citations (PDF) |
| 329 | Pressure overload induction of C-fosexpression in adult rat hearts is not blocked by angiotensin II type 1 receptor antagonist in vivo | 0.7 | 0 | Citations (PDF) |
| 330 | The role of nitric oxide (NO) in the beneficial effects of chronic exercise training on heart failure in awake dogs | 0.7 | 1 | Citations (PDF) |
| 331 | Arachidonic acid-induced dilation of epicardial coronary artery is maintained in awake dogs with chronic exercise training plus rapid cardiac pacing | 0.7 | 0 | Citations (PDF) |
| 332 | Nitric oxide (NO) is the mediator responsible for physical training-normalized vasodilation of epicardial coronary artery during development of heart failure (HF) | 0.7 | 1 | Citations (PDF) |
| 333 | Development of an intraluminal device for the treatment of aortic regurgitation: Prototype and in vitro testing system | 2.2 | 1 | Citations (PDF) |
| 334 | Evaluation of triple‐quantum‐filtered 23Na NMR in monitoring of intracellular na content in the perfused rat heart: Comparison of intra‐ and extracellular transverse relaxation and spectral amplitudes | 2.4 | 42 | Citations (PDF) |
| 335 | Existence of the Frank-Starling Mechanism in the Failing Human Heart | 13.1 | 226 | Citations (PDF) |
| 336 | Assessment of right ventricular contractile state with the conductance catheter technique in the pig | 5.7 | 91 | Citations (PDF) |
| 337 | Use of explanted human hearts as a model for the study of cardiac pathophysiologic conditions | 2.2 | 8 | Citations (PDF) |
| 338 | The hemodynamic basis for the cardiac effects of parathyroid hormone (PTH) and PTH-related protein. | 1.8 | 113 | Citations (PDF) |
| 339 | 901-10 Demonstration of Blood Flow Through Transmyocardial Laser Channels | 0.7 | 2 | Citations (PDF) |
| 340 | 932-91 Ventricular Interdependence in Explanted Human Hearts | 0.7 | 0 | Citations (PDF) |
| 341 | 727-2 Changes in Left Ventricular Mechanics and Energetics in Canine Microembolization Model of Heart Failure | 0.7 | 2 | Citations (PDF) |
| 342 | Reversal of Chronic Ventricular Dilation in Patients With End-Stage Cardiomyopathy by Prolonged Mechanical Unloading | 13.1 | 360 | Citations (PDF) |
| 343 | Impact of Isradipine on Contractile Performance, Metabolism, and Coronary Resistance Studied in Isolated Rat Hearts | 1.4 | 1 | Citations (PDF) |
| 344 | Explaining Load Dependence of Ventricular Contractile Properties with a Model of Excitation-Contraction Coupling | 2.7 | 38 | Citations (PDF) |
| 345 | Impact of Isradipine on Contractile Performance, Metabolism, and Coronary Resistance Studied in Isolated Rat Hearts | 1.4 | 0 | Citations (PDF) |
| 346 | Comparison between the effects of 2?3 dutanedione monoxime (BDM) and calcium chloride on myocardial oxygen consumption | 2.7 | 22 | Citations (PDF) |
| 347 | Effect of a bradycardic agent on the isolated blood-perfused canine heart | 1.2 | 21 | Citations (PDF) |
| 348 | Myocardial energetics and the postischemic heart | 2.6 | 15 | Citations (PDF) |
| 349 | Computer Model of Ventricular Interaction During Left Ventricular Circulatory Support | 0.3 | 3 | Citations (PDF) |
| 350 | Mechanically induced action potential changes and arrhythmia in isolated and in situ canine hearts | 5.7 | 185 | Citations (PDF) |
| 351 | Computer Model of Ventricular Interaction During Left Ventricular Circulatory Support | 0.3 | 12 | Citations (PDF) |
| 352 | In vitro studies of isolated supported human hearts | 0.7 | 25 | Citations (PDF) |
| 353 | Manuscript reviewer’s comment | 2.2 | 0 | Citations (PDF) |
| 354 | Influence of ventricular contractility on non-work-related myocardial oxygen consumption | 0.7 | 50 | Citations (PDF) |
| 355 | The similarity between ventricular pressure-volume relation and muscle force-length relation | 5.7 | 6 | Citations (PDF) |
| 356 | Pulmonary Circulation in Advanced Heart Failure and Cardiogenic Shock: State-of-the-Art Review | 2.7 | 3 | Citations (PDF) |
| 357 | Assessment of Ventriculo‐Arterial Interactions in Early and Undifferentiated Pulmonary Hypertension Using Wave Intensity Analysis | 3.1 | 0 | Citations (PDF) |
| 358 | Mechano-Ino-Chronotropic Unloading in Cardiogenic Shock Due to Acute Myocardial Infarction—Hemodynamic Insights From Simulation Modeling | 0.6 | 1 | Citations (PDF) |
| 359 | Phenotype-guided approach for device-based therapies in heart failure | 2.8 | 1 | Citations (PDF) |
| 360 | “Scientific revolutions are not so much the discovery of new facts as the re-arrangement of old ones in a new framework.” | 0.9 | 0 | Citations (PDF) |
| 361 | Author’s response to Moeller et al. | 1.4 | 0 | Citations (PDF) |
| 362 | Effect of large bore mechanical thrombectomy on pulmonary vascular resistance in patients with acute pulmonary embolism | 0.9 | 2 | Citations (PDF) |
| 363 | Impact of Age ≥75 Years on the Efficacy and Safety of Mechanical Circulatory Support Devices in Infarct-Related Cardiogenic Shock: Meta-Analysis With Individual Patient Data | 3.2 | 0 | Citations (PDF) |
| 364 | Pulmonary wave intensity analysis to assess ventriculo-arterial interactions in cardiogenic shock | 0.7 | 0 | Citations (PDF) |
| 365 | Cardiac Contractility Modulation for Patients With Heart Failure and Preserved Ejection Fraction: The AIM HIGHer Study | 0.9 | 0 | Citations (PDF) |
| 366 | Baroreflex Activation Therapy Invasive Hemodynamic “Reverse Ramp” Titration | 0.6 | 0 | Citations (PDF) |
| 367 | In Case You Missed It: Technology and Heart Failure Therapeutics 2026 | 0.9 | 0 | Citations (PDF) |
| 368 | Universal Pulmonary Resistance-Compliance Relationship – And Why It Matters? | 2.7 | 0 | Citations (PDF) |
| 369 | Does Characterization of Phenotypic Heterogeneity Provide Mechanistic Insights or Influence the Response to Treatment? Experience in Positive and Neutral Trials in Patients With Heart Failure and a Preserved Ejection Fraction | 13.1 | 0 | Citations (PDF) |
| 370 | V
0
-- the Loneliest Number That I Ever Knew | 2.7 | 0 | Citations (PDF) |
